Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cibus Inc CBUS

Healthcare Biotechnology
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant... see more

Recent & Breaking News (NDAQ:CBUS)

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

GlobeNewswire 8 days ago

Cibus to Participate in the 13th Annual Roth Technology Conference

GlobeNewswire 10 days ago

Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola

GlobeNewswire November 14, 2024

Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024

GlobeNewswire November 7, 2024

Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola

GlobeNewswire November 5, 2024

Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call

GlobeNewswire October 24, 2024

Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities

GlobeNewswire October 21, 2024

Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress

GlobeNewswire October 11, 2024

Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly

GlobeNewswire September 23, 2024

Cibus Announces Pricing of Public Offering of Class A Common Stock

GlobeNewswire September 18, 2024

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

GlobeNewswire September 17, 2024

Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape

GlobeNewswire September 10, 2024

Cibus to Participate in Upcoming August Investor Events

GlobeNewswire August 12, 2024

Cibus Reports Second Quarter Financial Results and Provides First Half Business Update

GlobeNewswire August 8, 2024

Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice

GlobeNewswire August 6, 2024

Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call

GlobeNewswire August 1, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS

Newsfile July 28, 2024

Levi & Korsinsky Reminds Cibus, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CBUS

Accesswire July 25, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS

PR Newswire July 24, 2024

ATTENTION Cibus, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

Accesswire July 24, 2024